Introduction: Dialysate-to-patient chloride mass transfer may occur during continuous veno-venous hemodialysis (CVVHD) with regional citrate anticoagulation (RCA). However, additional RCA-related ultrafiltration (UFRCA) and plasma chloride shifts to the intracellular compartment may impact mass transfer evaluation to an unknown extent. Methods: In an ancillary prospective, single-center study, we evaluated chloride mass transfer JS,Cl of adult patients treated with CVVHD-RCA. Chloride concentrations were measured in the effluent, and at filter’s inlet and outlet on the plasma side. JS,Cl was computed as the difference in chloride mass at the filter’s inlet and outlet in each compartment (i.e., dialysate and plasma water). A positive JS,Cl indicated chloride mass removal from plasma water. We accounted for the additional ultrafiltration volume performed automatically by the CVVHD monitor to account for citrate and CaCl2 administered volumes. Dialysate JS,Cl from the CLODICUS study (NCT04755491) were recomputed using this methodology. Results: We studied 10 patients with 18 observations. Dialysate JS,Cl was significantly lower than plasma JS,Cl (0.21 [0.07 to 0.24] vs. 0.31 [0.15 to 0.46] mmol.min−1, p < 0.05), indicative of chloride removal from plasma water not exclusively related to loss in the dialysate compartment. Chloride removal from plasma was significantly associated with greater decreases in plasma bicarbonate along the filter (p < 0.01). In the original CLODICUS study, UFRCA flow amounted to 207 (interquartile range: 172 to 217) mL.h−1, and the dialysate JS,Cl to 0.11 (−0.01 to 0.23) mmol.min−1. Increasing net ultrafiltration flow was associated with increasing dialysate JS,Cl. Conclusions: Plasma chloride mass removal during CVVHD-RCA is significantly greater than what is accounted for by dialysate-based loss, suggesting that plasma chloride is transferred to an intracellular compartment. Furthermore, to account for the online administration of citrate and CaCl2 solutions, CVVHD-RCA applies additional ultrafiltration, which significantly contributes to chloride removal from plasma water.

1.
Funk
GC
,
Doberer
D
,
Heinze
G
,
Madl
C
,
Holzinger
U
,
Schneeweiss
B
.
Changes of serum chloride and metabolic acid-base state in critical illness
.
Anaesthesia
.
2004
;
59
(
11
):
1111
5
.
2.
Yunos
NM
,
Bellomo
R
,
Hegarty
C
,
Story
D
,
Ho
L
,
Bailey
M
.
Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults
.
JAMA
.
2012
;
308
(
15
):
1566
72
.
3.
Chivot
M
,
Baldwin
I
,
Deniel
G
,
David
G
,
Eastwood
GM
,
Richard
JC
, et al
.
CaCl2-Citrate regional anticoagulation with continuous veno-venous haemodialysis leads to unwanted chloride loading compared to continuous veno-venous hemofiltration with systemic anticoagulation
.
Blood Purif
.
2024
;
53
(
11–12
):
893
903
.
4.
Paganini
EP
,
Flaque
J
,
Whitman
G
,
Nakamoto
S
.
Amino acid balance in patients with oliguric acute renal failure undergoing slow continuous ultrafiltration (SCUF)
.
Trans Am Soc Artif Intern Organs
.
1982
;
28
:
615
20
.
5.
Kaplan
AA
,
Longnecker
RE
,
Folkert
VW
.
Continuous arteriovenous hemofiltration. A report of six months’ experience
.
Ann Intern Med
.
1984
;
100
(
3
):
358
67
.
6.
Fresenius Medical Care
.
Multi version: multiFiltratePRO instructions for use. 6.0
.
Fresenius Med Care
;
2021
.
7.
Sigler
MH
,
Teehan
BP
.
Solute transport in continuous hemodialysis: a new treatment for acute renal failure
.
Kidney Int
.
1987
;
32
(
4
):
562
71
.
8.
Neri
M
,
Villa
G
,
Garzotto
F
,
Bagshaw
S
,
Bellomo
R
,
Cerda
J
, et al
.
Nomenclature for renal replacement therapy in acute kidney injury: basic principles
.
Crit Care
.
2016
;
20
(
1
):
318
.
9.
Waugh
WH
.
Utility of expressing serum sodium per unit of water in assessing hyponatremia
.
Metabolism
.
1969
;
18
(
8
):
706
12
.
10.
R Development Core Team
.
R: a language and environment for statistical computing
.
Vienna, Austria
:
R Foundation for Statistical Computing
;
2008
.
11.
Westen
EA
,
Prange
HD
.
A reexamination of the mechanisms underlying the arteriovenous chloride shift
.
Physiol Biochem Zool
.
2003
;
76
(
5
):
603
14
.
12.
Fabris
A
,
LaGreca
G
,
Chiaramonte
S
,
Feriani
M
,
Brendolan
A
,
Bragantini
L
, et al
.
The importance of ultrafiltration on acid-base status in a dialysis population
.
ASAIO Trans
.
1988
;
34
(
3
):
200
1
.
13.
Dalmark
M
.
Chloride in the human erythrocyte: distribution and transport between cellular and extracellular fluids and structural features of the cell membrane
.
Prog Biophys Mol Biol
.
1978
;
31
(
2
):
145
64
.
14.
Randoux
C
,
Gillery
P
,
Georges
N
,
Lavaud
S
,
Chanard
J
.
Filtration of native and glycated beta2-microglobulin by charged and neutral dialysis membranes
.
Kidney Int
.
2001
;
60
(
4
):
1571
7
.
15.
Yamamoto
K-I
,
Ogawa
T
,
Matsuda
M
,
Iino
A
,
Yakushiji
T
,
Miyasaka
T
, et al
.
Membrane potential and charge density of hollow-fiber dialysis membranes
.
J Membr Sci
.
2010
;
355
(
1–2
):
182
5
.
16.
Jaffrin
MY
.
Convective mass transfer in hemodialysis
.
Artif Organs
.
1995
;
19
(
11
):
1162
71
.
17.
Ronco
C
,
Canaud
B
,
Aljama
P
, editors.
Hemodiafiltration
.
S.Karger AG
;
2007
.
18.
Marques
FO
,
Libório
AB
,
Daher
EF
.
Effect of chloride dialysate concentration on metabolic acidosis in maintenance hemodialysis patients
.
Braz J Med Biol Res
.
2010
;
43
(
10
):
996
1000
.
19.
Chanard
J
,
Lavaud
S
,
Randoux
C
,
Rieu
P
.
New insights in dialysis membrane biocompatibility: relevance of adsorption properties and heparin binding
.
Nephrol Dial Transpl
.
2003
;
18
(
2
):
252
7
.
20.
Bihari
S
,
Taylor
S
,
Bersten
AD
.
Inadvertent sodium loading with renal replacement therapy in critically ill patients
.
J Nephrol
.
2014
;
27
(
4
):
439
44
.
You do not currently have access to this content.